Výsledky vyhledávání - "Tina Norsell"

In vitro stability of two formulations of recombinant activated factor viia reconstituted in inappropriate solvents or at inappropriate volumes

Autor: Anna B. Schönwandt, Michael Bech Jensen, Preben Þstfeldt, Tina Norsell, Hanne Nedergaard, Per B. Þstergaard, Jens Bjerre, Britt Petersson

Publikováno v: Clinical Therapeutics. 30:917-923

Background: Recombinant activated factor VIIa (rFVIIa) is indicated for on-demand treatment of bleeding and the prevention and treatment of surgical bleeding in patients with hemophilia A or B who have antibodies to coagulation factors VIII or IX. Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904200e3986bbdbe1648698b9ee0b2a2
https://doi.org/10.1016/j.clinthera.2008.05.001

Zobrazit plný text záznamu

In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature

Autor: Michael Bech Jensen, Jens Bjerre, Tina Norsell, Hanne Nedergaard, Pernille Theil Jensen, P. Østergaard, Susanne Vestergaard, Morten Wagner Kristiansen

Publikováno v: Clinical therapeutics. 30(7)

Recombinant activated factor VII (rFVIIa) is indicated to treat bleeding episodes or prevent bleeding related to surgery in patients with hemophilia A or B who have antibodies to coagulation factors VIII or IX. The first-generation rFVIIa formulation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a97b7480cee68ce69f14ba77d7af5fb5
https://pubmed.ncbi.nlm.nih.gov/18691990

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání